Will Intel's cash + short-term investments drop below $33B in any quarter of 2026?
Current Prediction
Why This Question Matters
Tests the reflexive coupling compound risk. The $37.4B FY25 exit cash position is the structural floor supporting >95% survival probability. Compound risk #1 warns that a bearish thesis scenario compresses cash toward $30B over 4 quarters. A drop below $33B without offsetting strategic events would signal the reflexive coupling materializing and would pressure FUNDING_FRAGILITY toward STRAINED — the label the stress-scanner bullet hole already argued for.
Prediction Distribution
Individual Predictions(9 runs)
The $33B threshold is only $4.4B below the $37.4B FY25 exit, and the question resolves YES on ANY quarter print — not year-end. Q1 2026 is the highest-risk quarter: sub-seasonal revenue guide ($12.2B mid, -11% QoQ), breakeven EPS, front-half-loaded CapEx, and FY25 adjusted FCF was still $(1.6)B. A $2-4B Q1 burn plus $2.5B planned debt retirement could flirt with $33B by quarter-end. However, management explicitly guided 'full-year positive adjusted FCF' and CapEx flat-to-down, and $9.7B CFO FY25 trending upward provides real cushion. The 'any quarter' framing drives probability meaningfully above the year-end base case.
The reflexive-coupling bear scenario (25-35% probability) compresses cash toward $30B over 4 quarters. But that scenario requires a 14A commit failure or rating action to materialize, which the committee treats as a mid-year trigger, not a Q1 event. Absent that trigger, Intel's stated FY26 plan — CapEx flat-to-down, positive adjusted FCF, $2.5B debt retirement — implies a net cash draw of perhaps $2-4B across the full year, distributed unevenly. Q1 is the most likely quarter for a transient dip given seasonality, but even a worst-case Q1 operating cash outflow of $2B plus $14-16B CapEx/4 would land cash near $34B, not below $33B, absent debt acceleration. Probability leans modestly below coin flip.
Three factors tilt higher than I initially thought. First, ST investment duration: $23.2B of the $37.4B is in ST investments whose quarter-end marks depend on reinvestment timing — the committee explicitly flagged this as a source of optical quarterly volatility. Second, mark-to-market volatility on escrowed strategic-partner shares ($1.8B FY25 non-cash loss) could repeat and hit the cash-equivalent line. Third, the adjusted FCF was $(1.6)B in FY25 and rising input costs (DRAM/NAND/substrate) were explicitly flagged on the Q4 call as a 2026 pressure. With any single quarter sufficient to resolve YES, transient dips become meaningful. I weight this above the year-end base case but still below coin flip because mgmt has guided positive FCF and has shown willingness to take strategic capital.
Math: Start $37.4B. FY26 plan = CFO $10-11B, CapEx net ~$12-13B, debt retirement $2.5B, positive adjusted FCF small. That implies a $1-3B full-year draw absent shocks, landing cash $34-36B at YE. For ANY quarter to print below $33B, you need either (a) concentrated Q1 burn plus front-loaded CapEx taking the trough to ~$33B, or (b) a mid-year bear-case trigger. Q1 scenario: $2B operating cash + $4B Q1 CapEx - $0.5B debt = $6.5B draw → $30.9B. That's below $33B. So Q1 alone could resolve YES under a pessimistic-but-not-absurd scenario. I weight this at ~35% probability because front-loaded CapEx is stated and Q1 is explicitly seasonally weak.
The committee's own monitoring threshold ($33B) was set precisely where it expected the trajectory to matter — not as a safe distance but as a tripwire. Combined with the 'any quarter' resolution criteria and the unresolved STRETCHED-vs-STRAINED debate (the bullet hole explicitly argued STRAINED on bear-case grounds), the market is asking whether the bear-case begins to materialize. Q1 2026 risk is elevated: sub-seasonal revenue ($12.2B mid, -11% QoQ), breakeven EPS, front-loaded CapEx, AND rising input costs on DRAM/NAND/substrate. The Foundry Stranding Cascade compound risk (25-35%) adds tail support. Probability below 50% because management has delivered on guide and has strategic levers, but the Q1 dip risk is real.
Management has real credibility here: $3.7B debt retired in H2 2025, $3.1B positive FCF in H2 2025 (improving trajectory), $9.7B CFO FY25 up 17%, OpEx target already beaten. The FY26 guide of 'full-year positive adjusted FCF' plus CapEx flat-to-down is specific and differs materially from FY25. Against $37.4B, a positive FCF year with $2.5B debt retirement implies roughly flat cash, landing Q4 2026 in the $35-37B band. The tail risk is Q1 concentration, but Intel management has historically managed cash tightly around quarter-ends and has $5B+ strategic partnership capital access if needed. I put this below coin flip, closer to the 25-30% tail-event range.
Starting cash $37.4B; threshold $33B is $4.4B away. Q1 2026 is seasonally weakest with sub-seasonal guide and front-loaded CapEx — highest-risk quarter. FY26 positive FCF guide and $2.5B debt retirement imply moderate draw. Any-quarter framing adds Q1 dip tail. Probability moderately below coin flip.
Management guided positive FCF and flat-to-down CapEx — this implies cash stays well above $33B in base case. The $4.4B buffer plus $10B CFO runs holds. Tail risk from Q1 seasonal trough and possible bear-case trigger keeps probability meaningful but below coin flip.
Any-quarter resolution amplifies Q1 dip risk. Q1 sub-seasonal revenue + breakeven EPS + front-loaded CapEx creates ~$4-6B concentrated draw, which against $37.4B could print $32-34B. ST investment roll adds optical volatility. Slightly elevated tail probability above one-third.
Resolution Criteria
Resolves YES if Intel's reported cash + short-term investments balance drops below $33.0B at the end of any quarter during fiscal year 2026 (Q1, Q2, Q3, or Q4 2026) as disclosed in 10-Q or 10-K balance sheet filings. Resolves NO if the balance remains at or above $33.0B at every 2026 quarter-end.
Resolution Source
Intel 10-Q and 10-K balance sheet filings for FY2026
Source Trigger
Cash + ST investments drops below $33B in any quarter without offsetting strategic event; below $30B = thesis under pressure
Full multi-lens equity analysis